Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate <i>in vivo</i>

Maria L.H. Vlaming(Oncode Institute), Alfred H. Schinkel(Oncode Institute), Olaf van Tellingen(Dutch Cancer Society), Anita van Esch, Els Wagenaar(The Netherlands Cancer Institute), Zeliha Pala(Istanbul University), Koen van de Wetering(Thomas Jefferson University)
Molecular Cancer Therapeutics
December 1, 2009
10.1158/1535-7163.mct-09-0668
Cited by 68

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
|PubMed|2002|688